These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Somatic cell engineering and the immunotherapy of leukemias and lymphomas. Brentjens RJ; Sadelain M Adv Pharmacol; 2004; 51():347-70. PubMed ID: 15464917 [No Abstract] [Full Text] [Related]
5. Aurora-A kinase: a novel target both for cellular immunotherapy and molecular target therapy against human leukemia. Ochi T; Fujiwara H; Yasukawa M Expert Opin Ther Targets; 2009 Dec; 13(12):1399-410. PubMed ID: 19821797 [TBL] [Abstract][Full Text] [Related]
6. Immunomodulation against leukemias and lymphomas: a realistic future treatment? Mittal S; Marshall NA; Barker RN; Vickers MA Crit Rev Oncol Hematol; 2008 Feb; 65(2):101-8. PubMed ID: 17719232 [TBL] [Abstract][Full Text] [Related]
7. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Waldmann TA; Dubois S; Tagaya Y Immunity; 2001 Feb; 14(2):105-10. PubMed ID: 11239443 [No Abstract] [Full Text] [Related]
8. [Pro and con: Immunotherapy in acute leukemia. Arguments for immunotherapy]. Büchner T; Urbanitz D Internist (Berl); 1980 Jul; 21(7):362-6. PubMed ID: 7007269 [No Abstract] [Full Text] [Related]
9. [Pro and con: Immunotherapy in acute leukemia. Arguments against immunotherapy]. Hirschmann WD Internist (Berl); 1980 Jul; 21(7):367-70. PubMed ID: 7007270 [No Abstract] [Full Text] [Related]
10. Cancer vaccines and immunotherapies: emerging perspectives. Henderson RA; Mossman S; Nairn N; Cheever MA Vaccine; 2005 Mar; 23(17-18):2359-62. PubMed ID: 15755628 [TBL] [Abstract][Full Text] [Related]
11. [PRAME protein expressed in leukemia cells as a target molecule for immunotherapy]. Ikeda H; Matsushita M; Kawakami H Rinsho Ketsueki; 1999 Jun; 40(6):484-6. PubMed ID: 10422284 [No Abstract] [Full Text] [Related]
12. Immunotherapy of hematological malignancies using dendritic cells. Van de Velde AL; Berneman ZN; Van Tendeloo VF Bull Cancer; 2008 Mar; 95(3):320-6. PubMed ID: 18390412 [TBL] [Abstract][Full Text] [Related]
13. Vaccines targeting tumor vasculature: a new approach for cancer immunotherapy. Croix BS Cytotherapy; 2007; 9(1):1-3. PubMed ID: 17354097 [No Abstract] [Full Text] [Related]
14. Chemo-immunotherapy versus chemotherapy in acute leukemia remission induction. Yu ZF; Lin MF; Wang BC; Lin XJ; Lin XH Chin Med J (Engl); 1981 Jan; 94(1):31-4. PubMed ID: 6785021 [No Abstract] [Full Text] [Related]
15. [Immunotherapy of hemato-oncologic diseases]. Winkler U; Bohlen H; Schirrmacher V; Schlimok G; Voliotis D; Brach M; Niederle N; Tesch H; Diehl V; Engert A Med Klin (Munich); 1996 Apr; 91(4):226-33. PubMed ID: 8692109 [No Abstract] [Full Text] [Related]
16. Tumor vaccines--application to childhood cancer. Roskrow MA; Zibert A; Souquet M; Dilloo D Klin Padiatr; 1999; 211(4):336-46. PubMed ID: 10472573 [TBL] [Abstract][Full Text] [Related]
18. Dendritic cell vaccines in acute leukaemia. Duncan C; Roddie H Best Pract Res Clin Haematol; 2008 Sep; 21(3):521-41. PubMed ID: 18790453 [TBL] [Abstract][Full Text] [Related]
19. Cancer vaccines: toward the next revolution in cancer therapy. Emens LA Int Rev Immunol; 2006; 25(5-6):259-68. PubMed ID: 17169776 [No Abstract] [Full Text] [Related]
20. Cancer vaccines: pessimism in check. Timmerman JM; Levy R Nat Med; 2004 Dec; 10(12):1279; author reply 1279-80. PubMed ID: 15682512 [No Abstract] [Full Text] [Related] [Next] [New Search]